SCHEMBL12419218

SCHEMBL12419218

CB(C)c1ccc2nccnc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
GAA P10253 2/20 0.39
GLA P06280 1/20 0.39
ADRA2A P08913 2/20 0.35
ADRA2C P18825 2/20 0.35
ALDH1A1 P00352 8/20 0.35
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 4/20 0.35
TP53 P04637 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MAPT P10636 6/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14421550 0.81 KMT2A (0.37) KMT2AMEN1GAAGLAADRA2A
SCHEMBL856485 0.77 ENPP2 (0.55) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL29952242 0.77 ENPP2 (0.55) KMT2AMEN1ALDH1A1HPGDMAPT
Hydrochloric Acid SCHEMBL994032 0.76 ENPP2 (0.53) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL30178501 0.69 ALDH1A1 (0.56) KMT2AMEN1GAAGLAALDH1A1
SCHEMBL27449 0.69 ALDH1A1 (0.56) KMT2AMEN1GAAGLAALDH1A1
SCHEMBL8337311 0.67 NPC1 (0.52) KMT2AMEN1GAAGLAADRA2A
SCHEMBL276632 0.65 ALDH1A1 (0.40) KMT2AMEN1GAAGLAADRA2A
SCHEMBL1612114 0.64 CHRNB4 (0.40) KMT2AMEN1GAAGLAADRA2A
SCHEMBL12281931 0.64 CA2 (0.35) ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 KMT2A 2097/4885MEN1 4220/4885GAA 344/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 KMT2A 2097/4885MEN1 4220/4885GAA 344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.